Geniposide Attenuates Hyperglycemia-Induced Oxidative Stress and Inflammation by Activating the Nrf2 Signaling Pathway in Experimental Diabetic Retinopathy

Geniposide (GEN) is a natural antioxidant and anti-inflammatory product and plays an important role in the treatment of diabetes and diabetic complications. To explore the biological functions and mechanism of GEN in diabetic retinopathy (DR), we constructed the in vitro and in vivo model of DR by using primary cultured mouse retinal Müller cells and C57BL/6 mice, respectively. We found that GEN inhibited ROS accumulation, NF-κB activation, Müller cell activation, and inflammatory cytokine secretion both in vitro and in vivo, which is probably mediated through the Nrf2 pathway. Exendin (9-39) (EX-9), an antagonist of glucagon-like peptide-1 receptor (GLP-1R), abolished the protective effect of GEN on high glucose- (HG-) induced Müller cells. Additionally, GEN decreased hyperglycemia-induced damage to Müller cells and blood-retinal barrier in the retinas of mice with DR. We demonstrated that GEN was capable of protecting Müller cells and mice from HG-induced oxidative stress and inflammation, which is mostly dependent on the Nrf2 signaling pathway through GLP-1R. GEN may be an effective approach for the treatment of DR.

[1]  Zhenzhen Wang,et al.  Melatonin attenuates oxidative stress and inflammation of Müller cells in diabetic retinopathy via activating the Sirt1 pathway. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  Xiaojuan Liu,et al.  Dysfunctional Nurr1 promotes high glucose-induced Müller cell activation by up-regulating the NF-κB/NLRP3 inflammasome axis , 2020, Neuropeptides.

[3]  Xiaodong Sun,et al.  A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells. , 2020, Experimental eye research.

[4]  Zhenzhen Wang,et al.  Melatonin inhibits Müller cell activation and pro‐inflammatory cytokine production via upregulating the MEG3/miR‐204/Sirt1 axis in experimental diabetic retinopathy , 2020, Journal of cellular physiology.

[5]  Zheng Li,et al.  Geniposide alleviates non‐alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways , 2020, Journal of cellular and molecular medicine.

[6]  Xijing He,et al.  β-Sitosterol-loaded solid lipid nanoparticles ameliorate complete Freund’s adjuvant-induced arthritis in rats: involvement of NF-кB and HO-1/Nrf-2 pathway , 2020, Drug delivery.

[7]  Jingyao Zhang,et al.  Methane Alleviates Acetaminophen-Induced Liver Injury by Inhibiting Inflammation, Oxidative Stress, Endoplasmic Reticulum Stress, and Apoptosis through the Nrf2/HO-1/NQO1 Signaling Pathway , 2019, Oxidative medicine and cellular longevity.

[8]  Yuanyuan Wei,et al.  Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  Qingguo Wang,et al.  Geniposide protects against hypoxia/reperfusion-induced blood-brain barrier impairment by increasing tight junction protein expression and decreasing inflammation, oxidative stress, and apoptosis in an in vitro system. , 2019, European journal of pharmacology.

[10]  Yan He,et al.  Geniposide attenuates cadmium-induced oxidative stress injury via Nrf2 signaling in osteoblasts , 2019, Molecular medicine reports.

[11]  B. Ye,et al.  C1q/TNF‐related protein‐9 attenuates retinal inflammation and protects blood–retinal barrier in db/db mice , 2019, European journal of pharmacology.

[12]  Q. Zhang,et al.  Attenuation of Myocardial ischemia reperfusion injury by Geniposide preconditioning in diabetic rats. , 2019, Current research in translational medicine.

[13]  Guibo Sun,et al.  Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy , 2019, Cells.

[14]  F. Zhou,et al.  Geniposide regulates the miR-101/MKP-1/p38 pathway and alleviates atherosclerosis inflammatory injury in ApoE-/- mice. , 2019, Immunobiology.

[15]  Xiao-long Chen,et al.  Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation , 2019, Experimental animals.

[16]  Giou-Teng Yiang,et al.  The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy , 2018, Oxidative medicine and cellular longevity.

[17]  Mahavir Singh,et al.  Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis , 2018, Front. Physiol..

[18]  K. Ward,et al.  Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy. , 2018, Investigative ophthalmology & visual science.

[19]  Dae-Duk Kim,et al.  Protective properties of geniposide against UV-B-induced photooxidative stress in human dermal fibroblasts , 2018, Pharmaceutical biology.

[20]  Ran Deng,et al.  Immunosuppressive Effect of Geniposide on Mitogen-Activated Protein Kinase Signalling Pathway and Their Cross-Talk in Fibroblast-Like Synoviocytes of Adjuvant Arthritis Rats , 2018, Molecules.

[21]  S. Mohr,et al.  Müller cells and diabetic retinopathy , 2017, Vision Research.

[22]  Jinlong Li,et al.  GLP-1 Treatment Improves Diabetic Retinopathy by Alleviating Autophagy through GLP-1R-ERK1/2-HDAC6 Signaling Pathway , 2017, International journal of medical sciences.

[23]  Lihua Liu,et al.  Naringin attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress and NF-κB activation in vivo and in vitro , 2017, Iranian journal of basic medical sciences.

[24]  R. Simó,et al.  GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe? , 2017, Diabetes.

[25]  Yu Cao,et al.  Genipin Inhibits LPS-Induced Inflammatory Response in BV2 Microglial Cells , 2017, Neurochemical Research.

[26]  G. Jin,et al.  Geniposide reduces development of streptozotocin‐induced diabetic nephropathy via regulating nuclear factor‐kappa B signaling pathways , 2017, Fundamental & clinical pharmacology.

[27]  A. Barber,et al.  Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy , 2016, Critical reviews in clinical laboratory sciences.

[28]  H. Hammes,et al.  Müller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid , 2014, The Journal of experimental medicine.

[29]  Z. Fu,et al.  Hypoxia-Induced Oxidative Stress in Ischemic Retinopathy , 2012, Oxidative medicine and cellular longevity.

[30]  Lixia Guo,et al.  Glucagon-like peptide 1 receptor plays an essential role in geniposide attenuating lipotoxicity-induced β-cell apoptosis. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[31]  L. Singh,et al.  TXNIP Links Innate Host Defense Mechanisms to Oxidative Stress and Inflammation in Retinal Muller Glia under Chronic Hyperglycemia: Implications for Diabetic Retinopathy , 2012, Experimental diabetes research.

[32]  Lin Zhu,et al.  The Absence of Nrf2 Enhances NF-κB-Dependent Inflammation following Scratch Injury in Mouse Primary Cultured Astrocytes , 2012, Mediators of inflammation.

[33]  Z. Xia,et al.  Glucagon-like peptide 1 receptor plays a critical role in geniposide-regulated insulin secretion in INS-1 cells , 2011, Acta Pharmacologica Sinica.

[34]  Lixia Guo,et al.  Geniposide induces the expression of heme oxygenase-1 via PI3K/Nrf2-signaling to enhance the antioxidant capacity in primary hippocampal neurons. , 2010, Biological & pharmaceutical bulletin.

[35]  G. A. Limb,et al.  Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE) , 2010, Diabetologia.

[36]  Wei Xu,et al.  Geniposide inhibits high glucose-induced cell adhesion through the NF-κB signaling pathway in human umbilical vein endothelial cells , 2010, Acta Pharmacologica Sinica.

[37]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[38]  N. Osborne,et al.  Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects , 2009, Progress in Retinal and Eye Research.

[39]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[40]  Masayuki Yamamoto,et al.  Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. , 2006, The Journal of clinical investigation.

[41]  E. Park,et al.  Anti-inflammatory evaluation of gardenia extract, geniposide and genipin. , 2006, Journal of ethnopharmacology.

[42]  D. Templeton,et al.  Thiol oxidation of cell signaling proteins: Controlling an apoptotic equilibrium , 2004, Journal of cellular biochemistry.

[43]  Sujay K. Singh,et al.  Hydrogen Peroxide Activates NF-κB through Tyrosine Phosphorylation of IκBα and Serine Phosphorylation of p65 , 2003, Journal of Biological Chemistry.

[44]  K. Itoh,et al.  Roles of Nrf2 in activation of antioxidant enzyme genes via antioxidant responsive elements. , 2002, Methods in enzymology.

[45]  A. Reichenbach,et al.  Role of Muller cells in retinal degenerations. , 2001, Frontiers in bioscience : a journal and virtual library.